Option Care Health (NASDAQ:OPCH) Raised to “Buy” at Bank of America

Option Care Health (NASDAQ:OPCH) was upgraded by research analysts at Bank of America from a “neutral” rating to a “buy” rating in a research note issued to investors on Monday. The firm presently has a $33.00 price target on the stock, up from their previous price target of $26.00. Bank of America‘s price target suggests a potential upside of 20.00% from the company’s current price.

Several other equities research analysts have also issued reports on the stock. Jefferies Financial Group lowered shares of Option Care Health from a “buy” rating to a “hold” rating and lowered their target price for the stock from $38.00 to $26.00 in a research note on Thursday, October 31st. Truist Financial decreased their price target on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research note on Friday, November 1st. JMP Securities reaffirmed a “market outperform” rating and issued a $30.00 price target (down from $31.00) on shares of Option Care Health in a research note on Friday. UBS Group initiated coverage on shares of Option Care Health in a research note on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price target on the stock. Finally, Barrington Research decreased their price target on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a research note on Thursday, October 31st. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $29.71.

Option Care Health Stock Performance

OPCH traded up $3.51 during midday trading on Monday, hitting $27.50. 2,739,009 shares of the company were exchanged, compared to its average volume of 1,643,684. The company’s 50 day simple moving average is $23.10 and its 200 day simple moving average is $27.69. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health has a 1-year low of $21.39 and a 1-year high of $34.63. The firm has a market capitalization of $4.68 billion, a price-to-earnings ratio of 23.11, a price-to-earnings-growth ratio of 2.43 and a beta of 1.31.

Insiders Place Their Bets

In other news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the business’s stock in a transaction dated Friday, November 8th. The stock was acquired at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the acquisition, the director now directly owns 326,334 shares of the company’s stock, valued at approximately $7,355,568.36. This represents a 15.18 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.64% of the company’s stock.

Institutional Trading of Option Care Health

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. GAMMA Investing LLC increased its holdings in shares of Option Care Health by 110.6% during the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock worth $28,000 after buying an additional 471 shares during the last quarter. Lindenwold Advisors INC increased its holdings in Option Care Health by 5.4% in the 3rd quarter. Lindenwold Advisors INC now owns 9,548 shares of the company’s stock valued at $299,000 after purchasing an additional 489 shares during the last quarter. Trust Point Inc. increased its holdings in Option Care Health by 2.6% in the 3rd quarter. Trust Point Inc. now owns 24,124 shares of the company’s stock valued at $755,000 after purchasing an additional 622 shares during the last quarter. Orion Portfolio Solutions LLC increased its holdings in Option Care Health by 2.3% in the 3rd quarter. Orion Portfolio Solutions LLC now owns 28,232 shares of the company’s stock valued at $884,000 after purchasing an additional 636 shares during the last quarter. Finally, Central Pacific Bank Trust Division increased its holdings in Option Care Health by 6.9% in the 4th quarter. Central Pacific Bank Trust Division now owns 10,079 shares of the company’s stock valued at $234,000 after purchasing an additional 650 shares during the last quarter. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.